RxDoctor Payments Data

Anthony Sisk, DO

Anatomic Pathology · Los Angeles, CANPI 1619294923

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $77,915 of the $79,487 with a category attached, or 98.0%. Agilent Technologies, Inc. accounts for 80.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $49,590 and has fallen 85.9% since, to $6,972 in 2024. Among anatomic pathology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,487in general payments, 2019–2025

Across 23 payments — averaging $3455.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Agilent Technologies, Inc.$64K
  • Leica Microsystems Inc.$9K
  • AbbVie$7K

What the payments were for

  • Consulting fees$77,91598%
  • Travel & lodging$1,0831%
  • Food & beverage$4891%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Agilent Technologies, Inc.8$63,815
Leica Microsystems Inc.6$8,700
AbbVie9$6,972

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,487 in reported general payments places this provider in the 90th percentile of 154 anatomic pathology providers in California.

See all anatomic pathology providers in California

Medicare billing

Part B allowed, 2024
$96,150
Medicare patients
411
Services billed
1,592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →